Lexicon Pharmaceuticals
LXRX
#6705
Rank
โ‚น74.85 B
Marketcap
โ‚น168.12
Share price
-1.65%
Change (1 day)
29.91%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): -โ‚น13.11

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น13.15. In 2025 the company made an earnings per share (EPS) of -โ‚น13.15 an increase over its 2024 EPS that were of -โ‚น60.11.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น13.11-0.28%
2025-โ‚น13.15-78.13%
2024-โ‚น60.11-20%
2023-โ‚น75.1431.15%
2022-โ‚น57.29-0%
2021-โ‚น57.2910.91%
2020-โ‚น51.66-145.08%
2019โ‚น114.59-206.09%
2018-โ‚น108.01-5.74%
2017-โ‚น114.59-10.95%
2016-โ‚น128.672640%
2015-โ‚น4.70-96.34%
2014-โ‚น128.17-2.53%
2013-โ‚น131.49-9.09%
2012-โ‚น144.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,784-13,664.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น553.20-4,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น4,412-33,657.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น487.46 3,607.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น243.26-1,950.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น1.88-85.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น70.44 435.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-โ‚น8.45-35.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น2,751 20,821.43%๐Ÿ‡บ๐Ÿ‡ธ USA